Related references
Note: Only part of the references are listed.Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
Benjamin J. Park et al.
AIDS (2009)
Antifungal drug susceptibility of Cryptococcus neoformans from clinical sources in Nairobi, Kenya
Christine C. Bii et al.
MYCOSES (2007)
Population-based surveillance for cryptococcosis in an antiretroviral-naive South African province with a high HIV seroprevalence
Kerrigan M. McCarthy et al.
AIDS (2006)
Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: The role of fluconazole resistance and immune reconstitution
Tihana Bicanic et al.
CLINICAL INFECTIOUS DISEASES (2006)
Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004)
MA Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Cryptococcal meningitis
T Bicanic et al.
BRITISH MEDICAL BULLETIN (2005)
Multicenter evaluation of commercial frozen plates for microdilution broth antifungal susceptibility testing of yeasts and comparison of MIC limits recommended in NCCLS M27-A2
K Makimura et al.
MICROBIOLOGY AND IMMUNOLOGY (2005)
Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates:: April 2000 to March 2002
B Sar et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults
N French et al.
AIDS (2002)
Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States:: 1992 to 1994 and 1996 to 1998
ME Brandt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
